Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes

Hemodialysis International

Volumn 14, Issue 4, 2010, Pages 387-392

  Pakfetrat, Maryam ^a   Nikoo, Mohamad Hosein ^b   Malekmakan, Leila ^a   Tabande, Mahmood ^c   Roozbeh, Jamshid ^a   Ganbar Ali, Raiss Jalali ^a   Khajehdehi, Parviz ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Kowsar Hospital   (Iran)

Author keywords

Contrast related acute kidney injury; Diabetes mellitus; Risk factor

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; INSULIN; IODIXANOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RISK FACTOR;

ACUTE KIDNEY INJURY; AGED; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCHOLESTEROLEMIA; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77958525985     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00469.x     Document Type: Article

References (32)

1. Bouzan-Mosquera A, Vazquez-Rodriguez JM, Calvino-Santos R, et al. Contrast-induced nephropathy and acute, renal failure following emergent cardiac catheterization: Incidence, risk factors and prognosis. Rev Esp Cardiol. 2007; 60:1026-1034.
2. Brown JR, Devries JT, Piper WD, et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J. 2008; 155:260-266.
3. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004; 44:1393-1399.
4. Schrader R. Contrast material-induced renal failure: An overview. J Interv Cardiol. 2005; 18:417-423.
5. Solmon R, Barrett B. Follow up of patients with contrast-induced nephropathy. Kidney Int. 2006; 100:46-50.
6. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 2006; 29:84-93.
7. Pakfetrat M, Nikoo MH, Malekmakan L, et al. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: A randomized, double-blind trial. Int Urol Nephrol. 2009; 41:629-634 [Epub January 10, 2009].
8. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005; 68:14-22.
9. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant. 2005; 20:1542-1550.
10. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006; 98:27-36.
11. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. New Eng J Med. 2006; 354:2473-2483.
12. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricemia: To treat or not to treat. Cleve Clin J Med. 2002; 69:594-608.
13. National Cholesterol Education Program. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-2497.
14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8:R204-R212.
15. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: A clinical and evidence-based approach. Circulation. 2006; 113:1799-1806.
16. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast associated renal dysfunction: Incidence and risk factors. Am J Roentgenol. 1991; 157:49-58.
17. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol. 2003; 284:F1121-F1137.
18. Palm F, Hansell P, Ronquist G, Waldenström A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia. 2004; 47:1223-1231 [Epub June 30, 2004].
19. Katavetin P, Miyata T, Inagi R, et al. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol. 2006; 17:1405-1413.
20. Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin Exp Pharmacol Physiol. 2006; 33:997-1001.
21. Galen MP Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction. Hypertension. 1998; 31:1047-1060.
22. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105:2259-2264.
23. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial: The Iohexol cooperative study. Kidney Int. 1995; 47:254-261.
24. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolarity vs low-osmolarity contrast media: Randomized clinical trial. Radiology. 1992; 182:649-655.
25. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int. 1992; 42:1274-1279.
26. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal haemodynamics and oxygenation: A role in contrast medium-induced nephropathy. Nephrol Dial Transplant. 2005; 20 (Suppl 1):i6-i11.
27. Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity; protective role of arginine. Kidney Int. 1998; 33:1736-1742.
28. Yang DW, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hyper cholesterolemia aggravates contrast media-induced nephropathy. Chin Med J. 2004; 117:542-546.
29. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404:787-790.
30. Freeman RV, O'Donnell M, Share D, et al. Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneouscoronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002; 90:1068-1073.
31. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006; 67:227-235.
32. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989; 86:649-652.